In Brief: Servier, IDEAYA Partner On Darovasertib For Uveal Melanoma

 
• By Mary Jo Laffler
  
Eye
Darovasertib is in late-stage development for the rare eye cancer uveal melanoma • Source: Shutterstock

More from Deals

More from Business